Certara, Inc. (NASDAQ:CERT) Shares Bought by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. grew its position in Certara, Inc. (NASDAQ:CERT) by 6.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 211,224 shares of the company’s stock after purchasing an additional 13,500 shares during the quarter. Oppenheimer Asset Management Inc. owned approximately 0.13% of Certara worth $2,473,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of CERT. Sei Investments Co. raised its stake in Certara by 39.5% in the second quarter. Sei Investments Co. now owns 997,871 shares of the company’s stock valued at $13,821,000 after buying an additional 282,357 shares in the last quarter. Silvercrest Asset Management Group LLC raised its position in shares of Certara by 27.3% during the 1st quarter. Silvercrest Asset Management Group LLC now owns 516,300 shares of the company’s stock worth $9,231,000 after acquiring an additional 110,636 shares in the last quarter. Daventry Group LP lifted its stake in Certara by 153.0% during the second quarter. Daventry Group LP now owns 1,308,572 shares of the company’s stock worth $18,124,000 after purchasing an additional 791,405 shares during the last quarter. Kayne Anderson Rudnick Investment Management LLC boosted its holdings in Certara by 8.4% in the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 810,206 shares of the company’s stock valued at $11,221,000 after purchasing an additional 62,912 shares in the last quarter. Finally, Clearbridge Investments LLC increased its stake in Certara by 0.8% in the first quarter. Clearbridge Investments LLC now owns 4,173,195 shares of the company’s stock valued at $74,617,000 after purchasing an additional 32,846 shares during the last quarter. 73.96% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Robert W. Baird reduced their price objective on shares of Certara from $18.00 to $13.00 and set a “neutral” rating for the company in a research report on Tuesday, November 5th. UBS Group upgraded shares of Certara from a “neutral” rating to a “buy” rating and set a $16.00 price objective for the company in a research note on Friday, September 27th. Finally, Barclays cut their target price on Certara from $14.00 to $12.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 7th. Six investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, Certara has a consensus rating of “Hold” and an average price target of $15.92.

Insider Buying and Selling at Certara

In other news, insider Leif E. Pedersen sold 51,224 shares of Certara stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $11.29, for a total value of $578,318.96. Following the sale, the insider now owns 99,704 shares of the company’s stock, valued at $1,125,658.16. The trade was a 33.94 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Patrick F. Smith sold 5,409 shares of the stock in a transaction dated Monday, October 7th. The stock was sold at an average price of $11.03, for a total transaction of $59,661.27. Following the transaction, the insider now directly owns 50,091 shares of the company’s stock, valued at $552,503.73. This represents a 9.75 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.39% of the company’s stock.

Certara Stock Down 5.4 %

Shares of NASDAQ:CERT opened at $9.96 on Friday. Certara, Inc. has a 1-year low of $9.88 and a 1-year high of $19.87. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.86 and a quick ratio of 2.86. The stock has a market cap of $1.60 billion, a P/E ratio of -49.80, a P/E/G ratio of 5.46 and a beta of 1.51. The firm has a fifty day moving average price of $10.90 and a 200 day moving average price of $13.46.

Certara (NASDAQ:CERT) last announced its earnings results on Wednesday, November 6th. The company reported $0.13 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.02. The business had revenue of $94.80 million during the quarter, compared to the consensus estimate of $95.51 million. Certara had a negative net margin of 8.34% and a positive return on equity of 3.43%. The business’s quarterly revenue was up 10.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.06 earnings per share. Sell-side analysts predict that Certara, Inc. will post 0.28 EPS for the current year.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.